BioNTech SE (BNTX) Operating Leases (2018 - 2024)

BioNTech SE (BNTX) has 6 years of Operating Leases data on file, last reported at $271.6 million in Q4 2024.

• For the quarter ending Q4 2024, Operating Leases rose 16.5% year-over-year to $271.6 million; the trailing twelve-month figure through Dec 2024 stood at $271.6 million (up 16.5% YoY), and the FY2024 full-year result was $271.6 million, up 16.5% from the prior year.
• Operating Leases climbed to $271.6 million in Q4 2024, from $233.2 million in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $271.6 million in Q4 2024 to a low of $207.7 million in Q4 2021.
• A 4-year average of $230.0 million and a median of $222.9 million in 2023 frame the typical range for Operating Leases.
• Across the five-year window, Operating Leases increased 3.18% in 2022 and gained 16.5% in 2024, its largest moves.
• Tracing BNTX's Operating Leases over 4 years: stood at $207.7 million in 2021, then grew by 3.18% to $214.4 million in 2022, then climbed by 8.77% to $233.2 million in 2023, then climbed by 16.5% to $271.6 million in 2024.
• Business Quant data shows BNTX's Operating Leases at $271.6 million in Q4 2024, $233.2 million in Q4 2023, and $222.9 million in Q1 2023.